Full panel

60+ Biomarkers

Quantified from one saliva sample by mass spectrometry, in our own labs.

Analytical performance

Consistent by design.

A number you can’t repeat is a number you can’t trust. We tested how reproducible the panel measures one sample within a run, between independently prepared runs, and across a change of instrument, and assessed it against ICH M10 (international guideline on bioanalytical method validation that the EMA and FDA apply).

These figures come from a controlled precision study on pooled saliva. Values in everyday practice, with real samples collected in the field, can differ from them.

0126/ 27meet the ICH M10 standardAt or under 15 % variation within and between runs. Two further markers are still in optimisation.
024.8%typical variationThe median spread of a single result on any given day.
0313%smallest real changeA larger change between two samples is very unlikely to be measurement noise.
041,000×dynamic range17 of 29 biomarkers quantified across three orders of magnitude.

Repeated measurements of one sample inside a single run. Every classified marker sits well under the ICH M10 limit.

0 %5 %10 %15 %20 %
ICH M10 limit
Want the full precision study?All 29 biomarkers on all three measures, on request.Request the full study ↗︎

How we tested

Pooled human saliva, untreated and with added reference compounds. Five independently calibrated runs on three days, from four independent preparations, each sample measured five to eight times per run: 61 quality control injections, each quantifying all 29 biomarkers.

Every biomarker is quantified against its own isotope labelled internal standard, and the results were recalculated independently of the instrument software.

What the charts show

The final method configuration: the two most recent runs, after the hardware change. Across all five runs the median variation between runs is 3.9 %, and 2.7 % in the final configuration. Prepared samples remeasured after 2.6 days moved by 0.1 % at the median.

What this study does not cover

It measures precision: whether the same sample gives the same answer. It does not measure agreement with an external reference method, which was not part of its scope.

Method parameters are proprietary. Full validation data is available under NDA, and every marker in the panel is listed on the biomarker page.

62 biomarkers · 10 groups

Steroid hormones8

  • CortisolLipidomics · Stress Glucocorticoid · Salivary Analysis

    Cortisol is the primary glucocorticoid hormone of the HPA axis, with salivary concentrations reflecting unbound bioactive free cortisol in plasma without the protein-binding interference present in serum measurements. It is the most extensively validated salivary hormone biomarker, used to quantify physiological stress, circadian rhythm integrity, and HPA axis reactivity across pain, fatigue, inflammation, and overtraining contexts. Chronically elevated salivary cortisol indicates maladaptive stress responses and increased catabolic drive.

    Read more about Cortisol →
  • CortisoneLipidomics · Cortisol Metabolite · Salivary Analysis

    Cortisone is the inactive glucocorticoid metabolite of cortisol, produced by 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) activity in salivary gland cells, and measurable in saliva at concentrations reflecting local glucocorticoid metabolism. Salivary cortisone tracks free cortisol availability and provides an independent measure of HPA axis output complementary to cortisol itself. The cortisol-to-cortisone ratio in saliva is a validated index of 11β-HSD enzyme activity and systemic glucocorticoid exposure.

    Read more about Cortisone →
  • TestosteroneSteroid Hormonomics · Anabolic Hormone · Salivary Analysis

    Testosterone is the primary anabolic androgen, produced mainly by Leydig cells in males and the adrenal cortex and ovaries in females, driving muscle protein synthesis, erythropoiesis, bone density, and competitive drive. Salivary testosterone represents the free, bioavailable fraction (approximately 1–3% of total) as it passively diffuses through salivary gland acinar cells, making it a highly sensitive index of bioavailable androgen status. Hackney et al. (2008) and Groeneveld et al. (2009) validated salivary testosterone as a reliable non-invasive alternative to serum for monitoring endocrine responses to training load.

    Read more about Testosterone →
  • DHEASSteroid Hormonomics · Adrenal Androgen · Salivary Analysis

    Dehydroepiandrosterone sulfate (DHEAS) is the sulfated storage form of DHEA, the most abundant circulating adrenal steroid, produced almost exclusively by the zona reticularis of the adrenal cortex and serving as a precursor for peripheral androgen and oestrogen synthesis. In salivary endocrinology, DHEAS reflects adrenal androgenic reserve and relative energy availability, declining with chronic overtraining, low energy availability, and hypothalamic-pituitary-adrenal axis suppression. Baulieu et al. (1998) characterised DHEAS biology as a neuroactive steroid relevant to exercise adaptation and recovery.

    Read more about DHEAS →
  • AndrostenedioneSteroid Hormonomics · Androgen Precursor · Salivary Analysis

    Androstenedione is a C-19 androgenic steroid produced by the adrenal glands and gonads, serving as a key intermediary in the biosynthesis of both testosterone and oestrone via aromatase. In salivary hormone profiling, androstenedione reflects the activity of the androgen biosynthetic pathway and adrenal androgenic drive, with elevations indicating heightened adrenal androgen production that may precede frank testosterone dysregulation in overtraining. As a direct testosterone precursor it provides mechanistic insight into the androgen:cortisol axis disruption observed in non-functional overreaching.

    Read more about Androstenedione →
  • ProgesteroneSteroid Hormonomics · Luteal Hormone · Salivary Analysis

    Progesterone is a C-21 steroid hormone produced by the corpus luteum, placenta, and adrenal cortex, playing central roles in the female reproductive cycle, thermogenesis, and neuroactive signalling as a precursor to allopregnanolone. Salivary progesterone measurement is well-validated in reproductive endocrinology and sports science, reflecting the bioavailable free fraction relevant to menstrual phase-dependent variations in exercise performance, recovery, and injury risk. Elliott-Sale et al. (2020) and Loucks (1998) established salivary progesterone monitoring as essential in female athlete health and relative energy deficiency assessment.

    Read more about Progesterone →
  • EstroneSteroid Hormonomics · Oestrogen Metabolite · Salivary Analysis

    Estrone (E1) is the primary oestrogen in post-menopausal women and a major circulating oestrogen produced by peripheral aromatisation of androstenedione in adipose tissue, adrenal glands, and liver. In female athletes, salivary estrone monitoring provides insight into oestrogen availability, bone density maintenance, and hypothalamic-pituitary-ovarian axis function, with suppressed levels indicating low energy availability and risk of the Female Athlete Triad or Relative Energy Deficiency in Sport (RED-S). Elliott-Sale et al. (2020) established salivary oestrogen monitoring as essential for comprehensive female athlete hormonal profiling.

    Read more about Estrone →
  • EstradiolSteroid Hormonomics · Primary Oestrogen · Salivary Analysis

    17β-Estradiol (E2) is the most potent endogenous oestrogen, produced mainly by ovarian granulosa cells and by peripheral aromatisation of testosterone, regulating the menstrual cycle, bone mineral density, substrate metabolism, and connective-tissue properties. Salivary estradiol captures the free, bioavailable fraction relevant to menstrual-phase effects on performance, recovery, and injury risk, and to detecting the low energy availability of RED-S. Elliott-Sale et al. (2020) and De Souza et al. (2010) established salivary oestrogen monitoring as central to female-athlete health.

    Read more about Estradiol →

Amino acids11

  • AlanineMetabolomics · Gluconeogenic Amino Acid · Salivary Analysis

    Alanine is a non-essential amino acid central to the glucose-alanine (Cahill) cycle, by which exercising muscle exports amino nitrogen to the liver for gluconeogenesis while disposing of pyruvate generated by glycolysis. Salivary alanine reflects the intensity of muscle glycolytic flux and inter-organ nitrogen shuttling during exercise. Felig and Wahren (1971) established the marked rise in alanine release from working muscle that defines this cycle.

    Read more about Alanine →
  • LeucineMetabolomics · Branched-Chain Amino Acid · Salivary Analysis

    Leucine is an essential branched-chain amino acid (BCAA) and the principal nutrient activator of the mTORC1 pathway driving post-exercise muscle protein synthesis, as well as a competitor with tryptophan for brain uptake relevant to central fatigue. Salivary leucine reflects BCAA availability and the anabolic and fatigue-modulating amino-acid balance around training. Blomstrand et al. (1991) demonstrated that BCAA provision during sustained exercise alters plasma amino-acid profiles and the central fatigue response.

    Read more about Leucine →
  • ProlineMetabolomics · Collagen Amino Acid · Salivary Analysis

    Proline is a non-essential cyclic amino acid and, together with hydroxyproline, the defining structural constituent of collagen, the principal protein of tendon, bone, and skeletal-muscle extracellular matrix. Salivary proline reflects connective-tissue amino-acid turnover, rising when collagen synthesis and degradation are accelerated by mechanical loading. Langberg et al. (1999) showed that exercise markedly increases peritendinous type I collagen turnover, the matrix in which proline predominates.

    Read more about Proline →
  • GlutamineMetabolomics · Immunonutrient Amino Acid · Salivary Analysis

    Glutamine is the most abundant free amino acid in plasma and skeletal muscle and a primary fuel for immune cells and enterocytes, positioning it at the interface of muscle metabolism and immune competence. A fall in glutamine availability has long been linked to the immunodepression and upper-respiratory infection risk seen with heavy training loads. Wenzel et al. (2026) measured salivary glutamine among the metabolites tracking exercise and recovery in a multi-omics strain model.

    Read more about Glutamine →
  • Glutamic acidMetabolomics · Excitatory Amino Acid · Salivary Analysis

    Glutamic acid (glutamate) is a non-essential amino acid functioning as the principal excitatory neurotransmitter and a hub of amino-acid metabolism, transamination, and the synthesis of glutamine and glutathione. Salivary glutamate reflects amino-acid flux and nitrogen handling that shift with muscular work and recovery. Wenzel et al. (2026) measured salivary glutamic acid among the metabolites that reliably track recent exercise within a multi-omics strain score.

    Read more about Glutamic acid →
  • Pyroglutamic acidMetabolomics · Glutathione Cycle Intermediate · Salivary Analysis

    Pyroglutamic acid (5-oxoproline) is an intermediate of the γ-glutamyl cycle of glutathione synthesis and turnover, accumulating when glutathione demand outstrips cysteine or glycine availability. Salivary pyroglutamic acid reflects the strain on the glutathione antioxidant system that defends tissues against exercise-induced reactive oxygen species. Sen et al. (1994) characterised the central role of glutathione redox status in exercise-induced oxidative stress and endurance.

    Read more about Pyroglutamic acid →
  • CitrullineMetabolomics · Nitric Oxide Precursor · Salivary Analysis

    Citrulline is a non-protein amino acid generated in the urea cycle and as a by-product of nitric oxide (NO) synthesis from arginine, and an efficient precursor for endogenous arginine and NO regeneration. Salivary citrulline reflects NO-pathway flux and ammonia handling relevant to vasodilation, substrate delivery, and fatigue resistance during exercise. Gonzalez and Trexler (2020) reviewed citrulline's role in enhancing NO bioavailability and exercise performance.

    Read more about Citrulline →
  • PhenylalanineMetabolomics · Essential Aromatic Amino Acid · Salivary Analysis

    Phenylalanine is an essential aromatic amino acid and the metabolic precursor to tyrosine and the catecholamine neurotransmitters, with circulating levels rising when net muscle protein breakdown exceeds synthesis. In saliva, phenylalanine serves as an index of proteolytic balance and amino-acid release following muscular work. Yi et al. (2025) identified salivary phenylalanine among the metabolites that vary after high-intensity rowing and screen for exercise-induced muscle damage.

    Read more about Phenylalanine →
  • TyrosineMetabolomics · Catecholamine Precursor Amino Acid · Salivary Analysis

    Tyrosine is a conditionally essential aromatic amino acid synthesised from phenylalanine and serving as the precursor for dopamine, noradrenaline, and adrenaline, the catecholamines driving arousal and the sympathetic exercise response. Salivary tyrosine reflects both proteolytic amino-acid release and catecholaminergic precursor demand under physical and psychological load. Yi et al. (2025) identified salivary tyrosine among metabolites varying after high-intensity rowing and screening for muscle damage.

    Read more about Tyrosine →
  • TaurineMetabolomics · Conditionally Essential Amino Acid · Salivary Analysis

    Taurine is a sulphur-containing conditionally essential amino acid highly concentrated in skeletal muscle, where it supports calcium handling, membrane stabilisation, osmoregulation, and antioxidant defence during contraction. Salivary taurine reflects muscular taurine status and efflux, which can shift with intense training load and accompany muscle fatigue. Wenzel et al. (2026) identified taurine among the salivary metabolites that track recent exercise within a multi-omics strain score.

    Read more about Taurine →
  • HistamineMetabolomics · Mast Cell Mediator · Salivary Analysis

    Histamine is a biogenic amine and primary mediator of mast cell and basophil degranulation in allergic, inflammatory, and immune activation responses, acting through H1-H4 receptors to amplify vascular permeability, smooth muscle contraction, and immune cell recruitment. In saliva, histamine reflects local oral mucosal mast cell activity and systemic histamine release associated with inflammation, food intolerance, exercise-induced urticaria, and overtraining-related immune dysregulation. Maintz and Novak (2007) characterised histamine's broad role in immune activation relevant to sport and health monitoring.

    Read more about Histamine →

Fatty acids and lipid mediators10

  • Arachidonic acidLipidomics · Pro-inflammatory Lipid · Salivary Analysis

    Arachidonic acid (AA, 20:4 n-6) is a polyunsaturated omega-6 fatty acid that serves as the primary substrate for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes producing prostaglandins, leukotrienes, and thromboxanes that drive the acute inflammatory response. In athletic contexts, salivary arachidonic acid reflects the omega-6 fatty acid availability for pro-inflammatory eicosanoid synthesis, with elevated levels associated with dietary omega-6 excess and amplified post-exercise inflammatory signalling. Calder (2017) established AA as a central lipid mediator in exercise-induced inflammation.

    Read more about Arachidonic acid →
  • Eicosapentaenoic acidLipidomics · Omega-3 Fatty Acid · Salivary Analysis

    Eicosapentaenoic acid (EPA, 20:5 n-3) is a long-chain omega-3 polyunsaturated fatty acid that competes with arachidonic acid for cyclooxygenase and lipoxygenase, yielding the less inflammatory 3-series eicosanoids and specialised pro-resolving mediators. Salivary EPA reflects long-chain omega-3 status and the capacity to resolve exercise-induced inflammation and support recovery. Calder (2017) established EPA as a central regulator of the inflammatory response and the omega-6/omega-3 balance in athletes.

    Read more about Eicosapentaenoic acid →
  • Linoleic acidLipidomics · Omega-6 Fatty Acid · Salivary Analysis

    Linoleic acid (LA, 18:2 n-6) is the most abundant omega-6 polyunsaturated fatty acid in the human diet and the metabolic precursor to arachidonic acid via delta-6-desaturase and elongase enzymes. In salivary lipidomics, linoleic acid reflects dietary omega-6 fatty acid status and the substrate availability for downstream pro-inflammatory eicosanoid synthesis; an imbalanced omega-6/omega-3 ratio is associated with amplified inflammatory responses to exercise and poor recovery. Calder (2017) established LA as a primary determinant of tissue eicosanoid profiles in athletes.

    Read more about Linoleic acid →
  • α-linolenic acidLipidomics · Omega-3 Fatty Acid · Salivary Analysis

    α-Linolenic acid (ALA, 18:3 n-3) is the essential plant-derived omega-3 polyunsaturated fatty acid and the metabolic precursor to the long-chain omega-3s EPA and DHA via desaturation and elongation. In salivary lipidomics ALA reflects dietary omega-3 intake and the substrate pool that biases tissue eicosanoid synthesis toward less inflammatory mediators. Calder (2017) established the omega-3 fatty acids, beginning with ALA, as primary determinants of the inflammatory response to exercise and recovery.

    Read more about α-linolenic acid →
  • Prostaglandin F2-alphaLipidomics · Inflammatory Eicosanoid · Salivary Analysis

    Prostaglandin F2-alpha (PGF2α) is a cyclopentane-ring eicosanoid synthesised from arachidonic acid via the cyclooxygenase pathway, acting as a potent mediator of inflammation, vasoconstriction, bronchoconstriction, and smooth muscle contraction following tissue injury. Salivary PGF2α is measurable as an index of COX-mediated inflammatory activity in the oral mucosa and systemic tissues, with elevated concentrations reflecting post-exercise tissue damage and arachidonic acid cascade activation. Ricciotti and FitzGerald (2011) comprehensively characterised prostaglandin biology relevant to exercise-induced inflammation.

    Read more about Prostaglandin F2-alpha →
  • Oleoyl ethanolamideLipidomics · Endocannabinoid Lipid · Salivary Analysis

    Oleoyl ethanolamide (OEA) is an N-acylethanolamine lipid mediator that acts as a PPAR-α agonist and endogenous modulator of pain, inflammation, and satiety signalling through non-cannabinoid receptor pathways. In the context of pain and analgesic monitoring, OEA levels reflect endocannabinoid tone and the body's endogenous anti-nociceptive response, with elevated concentrations indicating active pain modulation or NSAID use. It is part of the N-acylethanolamine family that counterbalances pro-inflammatory prostanoid signalling.

    Read more about Oleoyl ethanolamide →
  • Palmitoleoyl ethanolamideLipidomics · Endocannabinoid-like Lipid · Salivary Analysis

    Palmitoleoyl ethanolamide is a monounsaturated N-acylethanolamine, a minor member of the endocannabinoid-like lipid family derived from palmitoleic acid, modulating PPAR-α signalling, inflammation, and metabolic homeostasis. As a salivary lipid it forms part of the N-acylethanolamine signature responsive to physical effort and recovery state. Wenzel et al. (2026) identified palmitoleoyl ethanolamide among the salivary lipids that reliably distinguish recent exercise and contribute to a saliva-based internal-strain score.

    Read more about Palmitoleoyl ethanolamide →
  • Linoleoyl ethanolamideLipidomics · Endocannabinoid-like Lipid · Salivary Analysis

    Linoleoyl ethanolamide (LEA) is an N-acylethanolamine derived from linoleic acid that acts as a PPAR-α agonist and entourage modulator of endocannabinoid tone, influencing appetite, inflammation, and pain signalling. As a salivary lipid mediator it forms part of the N-acylethanolamine family that counterbalances pro-inflammatory eicosanoid signalling and shifts with physical and nutritional state. Piomelli (2000) established the fatty-acid-ethanolamide framework underlying this signalling system.

    Read more about Linoleoyl ethanolamide →
  • Arachidonoyl glycineLipidomics · Endocannabinoid-like Lipid · Salivary Analysis

    Arachidonoyl glycine (NAGly) is an endogenous lipoamino acid structurally related to the endocannabinoid anandamide, modulating pain, inflammation, and nociceptive signalling through GPR18 and related receptors without direct cannabinoid-receptor activation. As a salivary lipid mediator it forms part of the endocannabinoid-related signalling network relevant to pain modulation and the analgesic response. Woodhams et al. (2015) reviewed this system's role in pain, and Piomelli (2000) established its fatty-acid-amide framework.

    Read more about Arachidonoyl glycine →
  • Prostaglandin E2 ethanolamideLipidomics · Prostanoid Mediator · Salivary Analysis

    Prostaglandin E2 ethanolamide (PGE2-EA, prostamide E2) is a hybrid prostanoid-endocannabinoid lipid mediator formed at the intersection of the COX-2 and endocannabinoid pathways, contributing to both inflammatory pain sensitisation and nociceptive modulation. Its presence in saliva reflects active cyclooxygenase-mediated lipid inflammatory signalling and is relevant to monitoring NSAID and analgesic medication effects on the endocannabinoid system. Elevated levels indicate unresolved inflammatory pain states.

    Read more about Prostaglandin E2 ethanolamide →

Sleep, vitamins and lifestyle7

  • MelatoninLipidomics · Circadian Hormone · Salivary Analysis

    Melatonin is the primary circadian hormone secreted by the pineal gland during darkness, with salivary concentrations directly reflecting endogenous circadian phase and sleep onset timing. In athletes, suppressed melatonin indicates disruption from shift training, travel, or artificial light exposure. It is the gold-standard non-invasive measure of circadian alignment and sleep quality.

    Read more about Melatonin →
  • Nicotinic acidMetabolomics · NAD Precursor · Salivary Analysis

    Nicotinic acid (niacin, vitamin B3) is a water-soluble vitamin and direct precursor for nicotinamide adenine dinucleotide (NAD⁺/NADH), the central redox cofactor of cellular energy metabolism and mitochondrial oxidative phosphorylation. In saliva it reflects niacin status and the availability of NAD⁺ biosynthetic substrate underpinning exercise energy turnover. Ringseis et al. (2020) demonstrated that nicotinic acid availability enhances muscle oxidative adaptation and improves endurance performance.

    Read more about Nicotinic acid →
  • Nicotinuric acidMetabolomics · Niacin Metabolite · Salivary Analysis

    Nicotinuric acid is the glycine conjugate of nicotinic acid, an excretory metabolite marking niacin intake and the detoxification arm of vitamin B3 metabolism that feeds NAD⁺ biosynthesis. Salivary nicotinuric acid reflects niacin status and turnover relevant to the NAD⁺-dependent energy metabolism underpinning exercise capacity. Ringseis et al. (2020) linked nicotinic acid availability to muscle oxidative adaptation and endurance performance.

    Read more about Nicotinuric acid →
  • α-TocopherolLipidomics · Lipophilic Antioxidant Vitamin · Salivary Analysis

    α-Tocopherol is the most biologically active form of vitamin E, a lipophilic chain-breaking antioxidant that protects polyunsaturated fatty acids in cell membranes and lipoproteins from peroxidation. Salivary α-tocopherol reflects the lipid-phase antioxidant reserve available to buffer the reactive oxygen species generated during exercise. Finaud et al. (2006) reviewed vitamin E among the key antioxidant defences determining the oxidative-stress response to training.

    Read more about α-Tocopherol →
  • γ-TocopherolLipidomics · Lipophilic Antioxidant Vitamin · Salivary Analysis

    γ-Tocopherol is a major dietary form of vitamin E that, in addition to chain-breaking antioxidant activity, scavenges reactive nitrogen species that α-tocopherol does not efficiently neutralise. Salivary γ-tocopherol contributes to the lipid-phase antioxidant reserve buffering the oxidative and nitrosative stress of exercise. Finaud et al. (2006) reviewed the tocopherols among the antioxidant defences shaping the training oxidative-stress response.

    Read more about γ-Tocopherol →
  • TrigonellineMetabolomics · Caffeine Metabolite · Salivary Analysis

    Trigonelline is a major metabolite of caffeine and nicotinic acid catabolism measurable in saliva as an objective marker of recent stimulant intake and metabolic clearance rate. Salivary trigonelline levels are inversely associated with sleep quality, as higher concentrations reflect residual caffeine load that delays sleep onset and reduces slow-wave sleep duration. It provides a quantitative readout of stimulant burden relative to recovery windows.

    Read more about Trigonelline →
  • CotinineLipidomics · Nicotine Metabolite · Salivary Analysis

    Cotinine is the major proximate metabolite of nicotine and the gold-standard biomarker of tobacco and nicotine exposure, with a long half-life that makes it a stable index of recent use. In athlete monitoring, salivary cotinine provides an objective non-invasive measure of nicotine intake, whether from smoking, smokeless tobacco, or nicotine products increasingly used for purported ergogenic effect. Such intake can compromise cardiovascular and recovery health. Phillips et al. (1999) validated sensitive salivary cotinine quantification as a reliable exposure biomarker.

    Read more about Cotinine →

Kynurenine pathway3

  • TryptophanMetabolomics · Essential Amino Acid · Salivary Analysis

    Tryptophan is an essential aromatic amino acid serving as the sole precursor for serotonin, melatonin, and kynurenine pathway metabolites, making it a critical regulator of mood, sleep, immune function, and central fatigue signalling. During intense or prolonged exercise, plasma tryptophan depletion combined with elevated free fatty acids increases brain tryptophan uptake via reduced competition at the large neutral amino acid transporter, increasing serotonin synthesis and contributing to central fatigue. Cervenka et al. (2017) and Schrocksnadel et al. (2006) established tryptophan and its metabolite ratios as key markers of immune activation and neuroendocrine stress.

    Read more about Tryptophan →
  • KynurenineMetabolomics · IDO Pathway Metabolite · Salivary Analysis

    Kynurenine is the first major metabolite of tryptophan catabolism via the kynurenine pathway, produced from tryptophan by indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) in response to pro-inflammatory cytokines and glucocorticoids. Elevated kynurenine indicates activated tryptophan catabolism and is associated with immune activation, inflammation, psychological stress, and overtraining syndrome in athletes. Together with tryptophan and kynurenic acid, salivary kynurenine enables calculation of the Kyn/Trp ratio, a quantitative index of IDO enzyme activity central to Biolyz’s immune monitoring framework.

    Read more about Kynurenine →
  • Kynurenic acidMetabolomics · Neuroprotective Metabolite · Salivary Analysis

    Kynurenic acid is a neuroprotective metabolite of the kynurenine pathway, produced from kynurenine via kynurenine aminotransferase enzymes in peripheral tissues and the brain, with exercise promoting its synthesis through skeletal muscle PGC-1alpha1 activation. Agudelo et al. (2014) demonstrated that exercise-induced muscle PGC-1alpha1 drives kynurenic acid production, protecting the brain from stress-induced depression-like behaviour. In saliva, elevated kynurenic acid reflects active muscular exercise metabolism and indicates exercise-related neuroprotection.

    Read more about Kynurenic acid →

Purines and energy6

  • HypoxanthineMetabolomics · Purine Catabolite · Salivary Analysis

    Hypoxanthine is an intermediate purine catabolite produced from AMP dephosphorylation via IMP during high-intensity exercise when ATP resynthesis cannot keep pace with demand, reflecting the degree of adenine nucleotide degradation in skeletal muscle. Salivary hypoxanthine rises sharply with anaerobic exercise intensity and serves as a sensitive marker of energy depletion and purine nucleotide catabolism. Sahlin et al. (1991) established the relationship between muscle IMP accumulation and hypoxanthine release, forming the basis for its use as a muscular load and oxidative stress marker.

    Read more about Hypoxanthine →
  • XanthineMetabolomics · Purine Catabolite · Salivary Analysis

    Xanthine is the downstream oxidative catabolite of hypoxanthine, produced by xanthine oxidase during purine nucleotide degradation, and itself a substrate for uric acid production. The conversion of hypoxanthine to xanthine via xanthine oxidase generates reactive oxygen species, directly linking purine catabolism to oxidative stress during exercise recovery. Salivary xanthine, used in the xanthine/hypoxanthine ratio, provides a measure of xanthine oxidase flux and free radical generation proportional to exercise intensity.

    Read more about Xanthine →
  • cAMPMetabolomics · Second Messenger · Salivary Analysis

    Cyclic adenosine monophosphate (cAMP) is the canonical intracellular second messenger generated by adenylyl cyclase downstream of β-adrenergic and hormonal receptor activation, transducing catecholamine and glucagon signals into glycogenolysis, lipolysis, and contractile responses. Salivary cAMP reflects the systemic adrenergic and hormonal signalling tone associated with exercise stress and arousal. Wenzel et al. (2026) and Lindsey et al. measured salivary cAMP among markers tracking physiological strain and acute fatigue.

    Read more about cAMP →
  • 2'-deoxyguanosineMetabolomics · DNA Turnover Nucleoside · Salivary Analysis

    2'-Deoxyguanosine (dG) is the unmodified deoxyribonucleoside released during DNA turnover and repair, serving as the baseline reference against which its oxidised counterpart 8-hydroxy-2'-deoxyguanosine (8-OHdG) is quantified. Measured alongside 8-OHdG in saliva, 2'-deoxyguanosine enables normalisation of the oxidative DNA-damage ratios that rise with high-intensity and eccentric exercise. Valavanidis et al. (2009) established this nucleoside pairing as the basis of the gold-standard oxidative DNA-damage assay.

    Read more about 2'-deoxyguanosine →
  • CytosineMetabolomics · Pyrimidine Nucleobase · Salivary Analysis

    Cytosine is one of the four nucleobases of DNA and RNA, released into biofluids during nucleic-acid turnover, cell renewal, and salivary epithelial shedding. As a salivary metabolite it contributes to the nucleotide-metabolism fraction of the metabolome, reflecting tissue turnover and cellular proliferation rates. Its concentration provides background context for the purine and pyrimidine catabolites used to assess cellular stress and oxidative DNA damage.

    Read more about Cytosine →
  • N-lactoyl-phenylalanineMetabolomics · Exercise Metabolite · Salivary Analysis

    N-lactoyl-phenylalanine (Lac-Phe) is an exercise-inducible circulating metabolite produced in gut epithelial cells through the conjugation of lactate and phenylalanine, recently identified as a potent suppressor of feeding behaviour and adiposity in mammals. Li et al. (2022) in Nature demonstrated that Lac-Phe is one of the most strongly exercise-responsive metabolites in humans, with plasma levels rising in proportion to exercise intensity. As a salivary marker, it reflects the acute metabolic response to high-intensity muscular effort and energy expenditure.

    Read more about N-lactoyl-phenylalanine →

Creatine and hydration3

  • CreatinineSalivary Creatinine · Kidney Function Marker

    Creatinine is a metabolic waste product generated from the breakdown of creatine phosphate in muscle tissue. It is filtered from the blood by the kidneys at a relatively constant rate, making it a reliable endogenous marker of glomerular filtration rate (GFR) and overall kidney function.

    In salivary analysis, creatinine concentration provides a non-invasive window into both kidney clearance capacity and hydration status.

    Read more about Creatinine →
  • CreatineMetabolomics · Muscle Energy Marker · Salivary Analysis

    Creatine is a nitrogenous organic acid synthesised in the liver and kidneys from arginine and glycine, serving as the substrate for phosphocreatine resynthesis in skeletal muscle during high-intensity exercise. Salivary creatine reflects whole-body creatine pool status and is detectable via metabolomics, with concentrations rising post-exercise in proportion to phosphocreatine utilisation and muscle fibre recruitment. Papacosta and Nassis (2011) confirmed salivary monitoring of creatine-related metabolites as a feasible approach in athlete profiling.

    Read more about Creatine →
  • Protein ConcentrationMetabolomics · Hydration Marker · Salivary Analysis

    Total salivary protein concentration reflects the composite output of all proteins secreted into the oral cavity and rises inversely with salivary flow rate as dehydration progresses. Walsh et al. (2004) demonstrated strong correlation between salivary protein concentration and exercise-induced dehydration, validating it as a sensitive non-invasive fluid-balance marker. It complements creatinine as a dual-marker hydration assessment in athletic populations.

    Read more about Protein Concentration →

Oxidative stress3

  • NitrotyrosineMetabolomics · Nitrosative Stress Marker · Salivary Analysis

    3-nitrotyrosine (3-NT) is a stable end-product of tyrosine modification by peroxynitrite (formed from nitric oxide and superoxide), serving as a footprint of reactive nitrogen species (RNS) attack on proteins and a validated biomarker of nitrosative stress and protein nitration. In exercise physiology, salivary 3-nitrotyrosine rises in proportion to exercise intensity and duration, reflecting the combined generation of NO from muscle nNOS activation and superoxide from mitochondrial and xanthine oxidase sources during high-intensity training. Valavanidis et al. (2009) established protein nitration markers including nitrotyrosine as critical components of the oxidative stress biomarker panel.

    Read more about Nitrotyrosine →
  • 8-OHdGMetabolomics · Oxidative DNA Damage Marker · Salivary Analysis

    8-hydroxy-2’-deoxyguanosine (8-OHdG) is the most studied biomarker of oxidative DNA damage, formed by hydroxyl radical attack on the C-8 position of guanine within DNA, and repaired and excreted as a urinary and salivary metabolite reflecting total body oxidative stress burden. In sport science, salivary 8-OHdG rises significantly after high-intensity exercise, particularly eccentric exercise and hypoxic training, providing direct evidence of exercise-induced reactive oxygen species attacking genomic integrity. Valavanidis et al. (2009) reviewed 8-OHdG as the gold-standard oxidative DNA damage biomarker with clinical and athletic applications.

    Read more about 8-OHdG →
  • 7-ketocholesterolLipidomics · Oxysterol Oxidative Marker · Salivary Analysis

    7-ketocholesterol (7-KC) is the predominant oxysterol formed by free radical-mediated auto-oxidation of cholesterol at the C-7 position, accumulating in oxidatively stressed lipid membranes and lipoproteins, and exerting cytotoxic, pro-apoptotic, and pro-atherogenic effects. Salivary 7-ketocholesterol measured by lipidomics reflects systemic cholesterol oxidation and lipid peroxidation, providing a measure of membrane oxidative damage complementary to aqueous-phase oxidative stress markers like 8-OHdG. Vejux et al. (2009) characterised 7-ketocholesterol as a key cytotoxic oxysterol whose elevation indicates significant oxidative lipid damage relevant to overtraining and chronic inflammatory states.

    Read more about 7-ketocholesterol →

Bile acids7

  • Cholic acidMetabolomics · Primary Bile Acid · Salivary Analysis

    Cholic acid is a trihydroxy primary bile acid synthesised directly from cholesterol in the liver via the classic (neutral) bile acid synthesis pathway, conjugated to glycine or taurine before secretion into bile for lipid emulsification. As a salivary metabolite, cholic acid reflects hepatic cholesterol metabolism and bile acid synthesis capacity, with its ratio to secondary bile acids providing insight into gut microbiome composition and enterohepatic circulation dynamics. Disruptions in cholic acid metabolism are associated with hepatic stress, cholestasis, and altered gut microbiota composition relevant to elite athletic populations.

    Read more about Cholic acid →
  • Glycocholic acidMetabolomics · Conjugated Primary Bile Acid · Salivary Analysis

    Glycocholic acid is the glycine-conjugated form of the primary bile acid cholic acid, secreted into bile to emulsify dietary lipids and fat-soluble vitamins before reabsorption in the enterohepatic circulation. Salivary glycocholic acid reflects hepatic bile-acid conjugation and gut-liver axis dynamics that can shift with the altered gut motility and intestinal permeability of intense exercise. Chiang (2013) characterised the bile-acid conjugation and signalling underlying these processes.

    Read more about Glycocholic acid →
  • Glycochenodeoxycholic acidMetabolomics · Conjugated Primary Bile Acid · Salivary Analysis

    Glycochenodeoxycholic acid (GCDCA) is the glycine-conjugated form of the primary bile acid chenodeoxycholic acid, a potent FXR agonist central to bile-acid signalling, lipid absorption, and metabolic regulation. As a salivary bile acid it reflects enterohepatic circulation and gut-liver axis function, which are perturbed by the gut motility and permeability changes of prolonged exercise. Chiang (2013) detailed the metabolism and signalling roles of conjugated bile acids.

    Read more about Glycochenodeoxycholic acid →
  • Glycoursodeoxycholic acidMetabolomics · Conjugated Bile Acid · Salivary Analysis

    Glycoursodeoxycholic acid (GUDCA) is the glycine-conjugated form of the cytoprotective secondary bile acid ursodeoxycholic acid, contributing to lipid solubilisation and exerting anti-apoptotic and endoplasmic-reticulum-stress-reducing effects in hepatic and intestinal tissue. As a salivary bile acid it reflects enterohepatic circulation and gut-liver axis status, which shift with exercise-associated changes in gut motility and permeability. Wenzel et al. (2026) measured GUDCA among the salivary metabolites tracking recent exercise.

    Read more about Glycoursodeoxycholic acid →
  • Taurodeoxycholic acidMetabolomics · Secondary Bile Acid · Salivary Analysis

    Taurodeoxycholic acid (TDCA) is a taurine-conjugated secondary bile acid formed by hepatic conjugation of deoxycholic acid, functioning as a surfactant to facilitate dietary lipid and fat-soluble vitamin absorption in the small intestine. In salivary metabolomics, taurine-conjugated bile acids like TDCA reflect entero-hepatic circulation and gut microbiome-mediated bile acid transformation, with alterations observed during exercise-induced changes in gut motility and intestinal permeability. Siqueira et al. (2006) characterised salivary metabolomics as a window into systemic metabolic status including bile acid metabolism.

    Read more about Taurodeoxycholic acid →
  • Tauroursodeoxycholic acidMetabolomics · Cytoprotective Bile Acid · Salivary Analysis

    Tauroursodeoxycholic acid (TUDCA) is a taurine-conjugated ursodeoxycholic acid derivative with potent cytoprotective, anti-apoptotic, and endoplasmic reticulum stress-reducing properties, functioning to protect hepatocytes and other cells from bile acid toxicity and mitochondrial dysfunction. In salivary metabolomics, TUDCA levels reflect hepatic bile acid metabolism and cytoprotective signalling, which may be relevant to monitoring liver stress during prolonged endurance exercise. Its presence in saliva has been identified through untargeted metabolomics studies characterising the salivary metabolome.

    Read more about Tauroursodeoxycholic acid →
  • Tauromurocholic acidMetabolomics · Primary Bile Acid Conjugate · Salivary Analysis

    Tauromurocholic acid is a taurine-conjugated muricholic acid, a primary bile acid synthesised in the liver and typically found in rodents and at lower concentrations in humans, representing a minor conjugated bile acid detectable in salivary metabolomics profiling. Its detection in human saliva via mass spectrometry reflects the breadth of the salivary metabolome and hepatic bile acid conjugation activity. As part of the bile acid panel in salivary metabolomics, it contributes to a comprehensive picture of hepatic metabolic function and gut-liver axis status in athletes.

    Read more about Tauromurocholic acid →

Acylcarnitines4

  • OctanoylcarnitineLipidomics · Medium-Chain Acylcarnitine · Salivary Analysis

    Octanoylcarnitine (C8 acylcarnitine) is a medium-chain acylcarnitine formed when fatty-acid-derived acyl groups are shuttled into mitochondria for β-oxidation, and its abundance rises as fat oxidation is mobilised to fuel sustained activity. Salivary octanoylcarnitine therefore indexes the engagement of mitochondrial fatty-acid oxidation during exercise. Lehmann et al. (2010) showed that medium-chain acylcarnitines dominate the exercise metabolite signature and support lipid oxidation.

    Read more about Octanoylcarnitine →
  • DecanoylcarnitineLipidomics · Medium-Chain Acylcarnitine · Salivary Analysis

    Decanoylcarnitine (C10 acylcarnitine) is a medium-chain acylcarnitine generated during mitochondrial β-oxidation of fatty acids, its concentration rising as lipid oxidation is recruited to meet sustained energy demand. Salivary decanoylcarnitine indexes the engagement of fatty-acid oxidation during exercise. Wenzel et al. (2026) identified it among the salivary acylcarnitines distinguishing recent exercise, consistent with Lehmann et al. (2010) showing medium-chain acylcarnitines dominate the exercise metabolite signature.

    Read more about Decanoylcarnitine →
  • 2-trans-octenoylcarnitineLipidomics · Unsaturated Acylcarnitine · Salivary Analysis

    2-trans-Octenoylcarnitine is an unsaturated medium-chain acylcarnitine intermediate of mitochondrial fatty-acid β-oxidation, accumulating as acyl-CoA species are buffered through the carnitine shuttle during fat oxidation. Its salivary abundance tracks the mobilisation of mitochondrial lipid oxidation under exercise energy demand. Wenzel et al. (2026) identified it among the salivary acylcarnitines that reliably distinguish recent exercise, and Lehmann et al. (2010) showed medium-chain acylcarnitines dominate the exercise metabolite signature.

    Read more about 2-trans-octenoylcarnitine →
  • Tetradecanedioic acidLipidomics · Dicarboxylic Acid · Salivary Analysis

    Tetradecanedioic acid is a long-chain dicarboxylic acid produced by ω-oxidation of fatty acids, an auxiliary lipid-catabolic pathway upregulated when mitochondrial β-oxidation becomes saturated during prolonged exertion. Salivary dicarboxylic acids therefore mark the engagement of overflow fat-oxidation pathways under high endurance energy demand. Shi et al. (2020) reported significant elevation of dicarboxylic acids reflecting enhanced ω-oxidation in runners following a marathon.

    Read more about Tetradecanedioic acid →

In development6

markers on their way into routine.

Not reported yet, which is why they are not in the list.

  • Lactate
  • Vitamin D
  • IgA
  • IgG
  • Insulin
  • T4
Derived ratios sit on top of these: cortisol to cortisone, arachidonic acid to EPA, creatinine to creatine. That is how the production assay reaches 56 reportable markers from 48 measured analytes.
Dashboard

From value to meaning.

Get in touch

Let’s build your panel together.

Contact us ↗︎